drugset / Trial / NCT00004776
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
Phase 3
Completed
10 enrolled
National Center for Research Resources (NCRR)
University of California, Los Angeles · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Evaluate the safety and efficacy of oral topiramate in patients with Lennox-Gastaut syndrome.
Timeline
- Start
- 1993-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | — | Oral |